New Drug-Resistant Chinese Bird Flu Raises Concerns

Three out of 14 Chinese patients that contracted the new “Bird Flu,” otherwise known as the A/H7N9 virus, did not respond to Tamiflu, which is the only known treatment for the bird flu. In one patient in particular resistance to Tamiflu occurred most likely in response to the treatment itself, which led researchers to state that, “[t]he apparent ease with which antiviral resistance emerges in A/H7N9 is concerning; it needs to be closely monitored and considered in future pandemic response plans.”

Currently the global threat appears low, but the drug-maker Roche is taking the issue of resistance to Tamiflu “very seriously” and is collaborating with health authorities on the issue.

Read the original article here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s